Filing Details
- Accession Number:
- 0001694665-20-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-02 16:44:34
- Reporting Period:
- 2020-12-01
- Accepted Time:
- 2020-12-02 16:44:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1694665 | Evelo Biosciences Inc. | EVLO | Pharmaceutical Preparations (2834) | 465594527 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1805198 | Jacqueline Xiaoli Liu | 620 Memorial Drive Cambridge MA 02139 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-01 | 3,000 | $5.17 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.16 to $5.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Billionaire Hedge Funds
